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In previous work, we have demonstrated that Ras GTPases
regulate proliferation in a range of human renal cells. The
present work compares human and mouse mesangial cell
(HMC and MMC) responses to specific knockdown of Ras
genes with antisense oligonucleotides (AS-oligos), and
examines the role of the p21 (cip1) and p27 (kip1)
cyclin-dependent kinase inhibitors in these responses in
mouse cells. HMC and MMC were lipofectin transfected with
ras-targeted AS-oligo at 200–400 nM for 18 h followed by
growth of cells in 20% serum for 18–72 h. Cell proliferation
was assessed with an MTS assay and bromodeoxyuridine
(BrdU) uptake. Apoptosis was quantified using nuclear stain
with Hoechst 33342 dye. In MMC, Ha-ras AS-oligo caused an
increase in apoptosis fromo2% to 10–15% of cells after 18 h
in serum (Po0.01). Control, Ki-ras and N-ras AS-oligos had
minimal effects on apoptosis. BrdU uptake studies showed
that BrdUþ ve MMC were increased by 20–40% (Po0.05)
after Ha-ras AS-oligo at 24 h; other ras AS-oligos were
inactive. HMC number was reduced by 40–80% (Po0.01) at
48–72 h by both Ha-ras and Ki-ras AS-oligos. These actions
were associated with reductions in BrdUþ ve cells. In HMC,
the ras AS-oligos did not induce apoptosis. p21(,) MMC
showed exaggerated apoptotic responses to Ha-Ras AS-oligo.
In mouse cells, Ha-Ras expression appears necessary to
prevent apoptotic cell death; Ras expression does not appear
necessary for cells to progress through the cell cycle. In
human cells, Ras does not appear necessary to prevent
apoptosis but Ha-Ras and Ki-Ras appear to be required for
cell cycle progression.
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Renal disease is often characterized by dysregulation of
proliferation and apoptosis.1 Abnormal mesangial cell
proliferation is characteristic of several forms of human
glomerulonephritis and is associated with excess glomerular
cellularity, and with the damaging process of glomerular
sclerosis.2 An understanding of the cellular and molecular
basis for this response and the cell signaling pathways
involved is likely to lead to new targets for future therapies.
There has been considerable progress in dissecting the likely
extracellular factors that drive the proliferative response, and
the mitogenic cytokine platelet-derived growth factor appears
to have an important role.3–5 There is less complete
understanding of the intracellular signaling involved.
Ras monomeric GTPases play a critical role in the
control of cellular proliferation, differentiation and apop-
tosis, and are potential targets in renal therapies.6–9 There
are three different isoforms of Ras: Harvey (Ha-Ras),
Kirsten (Ki-Ras) and Neural (N-Ras). However, the distinct
functions of these species are poorly understood. The
upstream signals that control Ras activation include plate-
let-derived growth factor, fibroblast growth factor, epithelial
growth factor and a range of other mitogens that have been
implicated in renal disease. We have demonstrated in earlier
work that both Ki-Ras and Ha-Ras are required for cell
cycle progression in human renal fibroblasts.7 The present
work presents a study of the role of the Ras genes in
mesangial cells.
In classical cell biological models, such as NIH 3T3 cells,
there is abundant evidence for the role of the Ras family of
monomeric GTPases in the control of cell proliferation.6 The
three ras genes are all potent transforming agents when
mutated to be locked in the active GTP-bound form. Recent
studies have shown that renal cell proliferation is also
governed at the level of the cell cycle by regulatory proteins.
Specifically, cyclin-dependent kinase (CDK) inhibitors,
including p21 and p27, limit renal cell proliferation by
binding to and inhibiting cyclin–CDK complexes.10 However,
the regulation of the CDK inhibitors p21 and p27 is not well
understood in renal cells. There is recent evidence that the
transcription of p21 and the expression level of functional
p27 can be regulated by Ras in non-renal cells.11–13 However,
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in renal mesangial cells the relationships between the Ras
isoforms and p21 and p27 have not been defined.
The goal of the current work was to determine the roles
of the Ras GTPases in the control of proliferation and apop-
tosis in renal mesangial cells using ras antisense oligonucleo-
tides (AS-oligos), and to examine the possible interactions
between Ras and the CDK inhibitors p21 and p27. The results
obtained show that the roles of Ras genes are quite distinct
when mouse and human cells are compared. In human cells,
the Ki-Ras and Ha-Ras GTPases are required for stimulated
proliferation; in mouse cells, Ha-Ras is an antiapoptotic
survival signal but Ras is not needed for proliferative
signaling.
RESULTS
Cell number is altered by suppression of specific Ras isoforms
Figure 1 shows results determining the activity and specificity
of the ras AS-oligos using linear-range reverse transcriptase-
polymerase chain reaction (RT-PCR). Figure 1a displays
RT-PCR products using Ki-Ras(4B) primers on mRNA from
human mesangial cells (HMC) transfected with each of
the four AS-oligos. Incubation with the Ki-Ras AS-oligo at
200 nM for 16 h abolished the Ki-Ras(4B) RT-PCR product.
The 18S ribosomal bands were used to ensure equal loading
in each sample. The Ha-Ras and N-Ras AS-oligos and control
AS-oligo did not alter the levels of Ki-ras mRNA. Similarly,
Figure 1b shows that the Ha-Ras AS-oligo specifically
reduced Ha-Ras mRNA, which was not altered by the other
AS-oligos. Figure 1c similarly shows that the N-Ras AS-oligo
is specific in depletion of mRNA for its target isoform. These
results demonstrate specific actions of the three ras antisense
oligos on the levels of cellular mRNA for each isoform. Ras
protein half-life has been determined by pulse chase to be
18–24 h, and the specific knockdown of Ras protein 48 h after
transfection was found to be 480% (data not shown) as
reported previously for renal fibroblasts.7
In mouse mesangial cells (MMC), the control AS-oligo
was found to have no effect on the cell number curves when
compared with lipofectin-alone mock transfection condi-
tions. Figure 2a shows the cell number curves over 72 h for
wild-type MMC after transfection with each of the three
Ras AS-oligo compared with control AS-oligo transfection.
As expected, there was an increase in the cell count with time
under control conditions. This was not altered by transfec-
tion with N-ras or Ki-ras oligo. In contrast, there was a
small but significant suppression of the growth curve at 24 h
after Ha-Ras AS-oligo transfection but cell numbers were
unaffected at 48 and 72 h.
The growth curves for p21(,) MMC are shown in
Figure 2b. Cell number was not significantly altered in cells
transfected with Ki-Ras and N-Ras AS-oligo compared with
control AS-oligo. In contrast, there was significant growth
suppression after transfection with the AS-oligo targeting
Ha-Ras at 24, 48 and 72 h (Po0.01 versus control).
Figure 2c and d shows the results obtained in p27(/)
and double knockout p21(/)p27(/) MMC, respec-
tively. Transfecting these cells with each of the ras isoform
AS-oligos did not significantly alter cell number at 24–72 h.
The cell number curves for HMC are shown in Figure 3.
In human cells, the control AS-oligo caused a nonspecific
reduction in cell numbers at 48–72 h. A nonspecific action
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Figure 1 | Demonstration of specific actions of the ras oligos. In
each PCR panel, the upper band represents ras and the lower band
represent 18S ribosomal RNA control. (a) RT-PCR for Ki-ras after
transfection with each of the three ras oligos (Ha-ras, Ki-ras, N-ras)
and control oligo (ctrl). Similar results (b) for Ha-ras RT-PCR and (c) for
N-ras are shown.
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Figure 2 | Cell number as a function of time as monitored by the
MTS assay for MMC, and the actions of Ras knockdown by
isoform-specific oligos. The ordinates show cell number expressed
as arbitrary units. (a) Data from wild-type MMC, (b) data from
p21(,) MMC, (c) results for p27(,) MMC and (d) data for the
double knockout p21(,) p27(,) MMC. Error bars are s.e.m. Each
figure represents data from three independent experiments, each
performed in quadruplicate (n¼ 12). *Po0.05 versus control oligo
data; **Po0.01 versus control oligo data.
100 Kidney International (2006) 69, 99–104
o r i g i n a l a r t i c l e BM Hendry et al.: Ras GTPase functions in mouse and human mesangial cells
has been reported previously with this control AS-oligo in
human renal fibroblasts.7 In contrast to wild-type MMC,
transfecting HMC with the Ki-Ras and Ha-Ras AS-oligos
further suppressed cell number at 48–72 h significantly. N-ras
oligo did not alter cell number in HMC compared with the
control AS-oligo.
Further work to define the effects observed was performed
with the HMC and with the wild-type and p21(,) MMC.
Reducing Ha-Ras increases apoptosis in MMC
Figure 4 shows the levels of apoptosis in the wild-type and
p21(,) MMC and in HMC 24 h after transfection with
AS-oligos. In wild-type MMC, there was a clear increase in
apoptosis (by more than fivefold) after transfection with the
Ha-Ras oligo (Po0.01 versus control AS-oligo-transfected
cells), which was not evident in cells transfected with N-ras or
Ki-ras oligo. In p21(,) MMC, there was a 10-fold increase
in apoptosis after Ha-ras AS-oligo transfection. Ki-ras and
N-ras AS-oligos did not induce apoptosis. In HMC, in con-
trast, none of the Ras AS-oligos had an effect on apoptosis.
Figure 5 shows examples of wild-type MMC appearances
under fluorescent microscopy, illustrating the apoptosis
induced by Ha-Ras AS-oligo.
Ha-Ras regulates DNA synthesis
In order to determine whether the change in cell number was
due to changes in DNA synthesis, bromodeoxyuridine (BrdU)
staining was performed in AS-oligo-transfected and control
cells. The effects of the Ras oligo on BrdU uptake are shown in
Figure 6. In HMC, both the Ha-ras and Ki-ras oligo reduced
the proportion of BrdUþ ve cells by 20–40% (Po0.05 versus
control). In wild-type MMC, the Ha-ras AS-oligo caused a
significant increase in % BrdUþ ve cells; other Ras AS-oligos
were inactive. In p21(,) MMC, the AS-oligos did not
cause significant changes in BrdU uptake, although the Ha-ras
AS-oligo led to a tendency toward higher values.
Ha-ras and the expression of pAkt and the CDK inhibitors p21
and p27
We next asked whether specific ras isoforms alter the
expression of p21 or p27 and activation of the survival
protein Akt in the wild-type MMC. Figure 7 shows Western
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Figure 3 | Cell number as a function of time as monitored by the
MTS assay for HMC, and the actions of Ras knockdown by
isoform-specific oligos. The ordinate shows cell number expressed
as arbitrary units. Error bars are s.e.m. Data are shown from three
independent experiments, each performed in triplicate (n¼ 9).
*Po0.05 versus control oligo data, **Po0.01 versus control oligo
data.
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Figure 4 | Mean values for percentage apoptosis shown after
transfection of the HMC and MMC by the ras oligos. Mock
transfection with lipofectin (mock Tx) is compared to transfection
with 200 nM Ha-ras, Ki-ras, N-ras and control oligos. In all, 4150 cells
were counted for each experiment, and the mean of three
experiments is shown. Error bars are s.e.m. **Po 0.01 versus control
oligo for cells of the same genotype.
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Figure 5 | Illustration of the actions of ras oligo on apoptosis in
MMC. Cell nuclei are stained with Hoechst 33342 as described in the
text.
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Figure 6 | Mean percentage of BrdUþ ve cells after transfection
with oligos targeting Ras isoforms Ha, Ki and N or with control
oligo. Data for HMC are compared with wild-type and p21(,)
MMC. In all, 4150 cells were counted in each of three independent
experiments. Error bars are s.e.m. *Po0.05 versus control oligo.
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blot analysis demonstrating the effects of the Ras AS-oligos
on the expression of p21 and phospho-Akt in wild-type
MMC. As expected, the levels of p21 were increased from
baseline in wild-type cells on serum stimulation under
control conditions. This increase was partially suppressed by
the Ha-Ras AS-oligo, but not altered by the Ki-Ras and N-
Ras AS-oligos as quantified in the bar chart of Figure 7. The
expression of p27 was variable and was not significantly
altered by the different Ras AS-oligos (data not shown). The
results of phospho-Akt blotting did not show any significant
differences when the AS-oligos were compared.
DISCUSSION
These experiments on MMC showed a striking difference in
the sensitivity of p21(,) cells to Ha-Ras AS-oligo when
compared to the other genotypes. The normal growth curve
is completely flattened after Ha-Ras AS-oligo transfection
(Figure 2b). This action is explained by the dramatic increase
in apoptosis caused by this Ha-ras AS-oligo (Figure 4) and
does not appear to be related to any failure of cell cycle
progression, as BrdU uptake was not suppressed by Ha-Ras
oligo (Figure 6). The knockdown of Ha-Ras also caused clear
but lesser increases in apoptosis in the wild-type MMC. This
is reflected in the reduction in cell number at 24 h in the
wild-type cells after Ha-Ras knockdown (Figure 2a). The cell
number curve then returns to control levels at 48–72 h and
this is likely to be related to a compensatory increase in
proliferation in these cells, which is evident from the
observed increase in BrdU uptake (Figure 6). These mouse
wild-type mesangial cells appear to undergo an increase in
proliferation, which compensates for the cells lost by
apoptosis. These data specifically implicate Ha-Ras in the
prevention of apoptosis in MMC in serum. The p21(,)
cells are particularly sensitive to apoptosis following the loss
of Ha-Ras and this is consistent with the observation that
these cells are also more sensitive to the withdrawal of serum.
P21(cip1) has been implicated in transforming growth
factor-b responses and in the genesis of mesangial cell
hypertrophy.10,14 The present data suggest that p21 and
Ha-ras act together in some way to ensure mouse mesangial
cell survival in the presence of serum. Mouse cells null
for p27 appeared to behave like wild-type cells in these
experiments and p27 does not appear to influence the serum-
induced proliferation of MMC either positively or negatively.
In the light of this, it was surprising to find that the p21/p27
double knockout cells also behaved like wild-type cells in
these experiments. It appears that the link between p21 and
survival is uncoupled in the absence of p27. The reasons for
this are not clear.
The actions of Ras oligo on p21 and p27 protein levels
were small and may not have played a significant role in the
effects observed. However, it is of interest that the well-
described upregulation of p21 by serum was inhibited by
Ha-Ras AS-oligo and not by the other Ras AS-oligos (Figure 7).
Induction of p21 by certain cytokines (e.g. transforming
growth factor-b) appears to be Ras-dependent but for others
(e.g. platelet-derived growth factor) it is not.15 The present
data are consistent with the reported role of Ras GTPases in
the control of p21 transcription11,12,15 and specifically
implicate Ha-Ras in this regulation. This result suggests that
Ha-Ras alone is an important regulator of p21 protein levels.
Ras is classically thought to stimulate cell cycle progres-
sion and this action was observed in the HMC data where the
knockdown of Ha-Ras and Ki-Ras reduced the percentage of
cells in the S phase and reduced cell numbers in the MTS
assay (Figures 3 and 6). These actions are exactly as reported
in human renal fibroblasts.7 However, no such action was
observed in the mouse cells and indeed the percentage of cells
in the S phase was increased by knockdown of Ha-Ras.
The different effects of Ras knockdown on the cell
number curves in mice and humans (Figures 2 and 3) can
be explained by differential actions on apoptosis and the cell
cycle. In human cells, the knockdown of Ha-Ras or Ki-Ras is
antiproliferative with no changes in apoptosis. Cell numbers
are therefore reduced by Ha-Ras and Ki-Ras oligo. In mouse
cells, the large increase in apoptosis on knockdown of Ha-Ras
is partially offset by an increase in cell cycle progression,
leaving the cell numbers relatively unaltered except at the
early time point of 24 h. In mouse cells, Ki-Ras and N-Ras do
not appear to modulate apoptosis or cell cycle progression.
A likely downstream effector in the protection from
apoptosis exerted by Ha-Ras in MMC is the phosphatidyl-
inositol 30-kinase-phospho-Akt pathway.16,17 We could not
confirm a role for phospho-Akt, but cannot rule it out
entirely as the extracted protein at 24 h may provide
information only on the non-apoptotic cells and earlier time
points might be needed to observe altered phospho-Akt
preceding apoptosis. Another possible downstream modu-
lator of the actions of Ha-Ras in mouse cells is the Ral-GDS
system. Ha-Ras activity has been specifically linked to
Ral-GDS, and activity in this pathway is known to be able
to modulate apoptosis and cell differentiation.18 This
interaction requires further study in renal cells.
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Figure 7 | Western blot of p21(cip1) and pAkt expression in wild-
type MMC comparing the effects of ras oligos. Baseline data were
obtained before serum stimulation. Other data were obtained after
24 h in 20% serum after prior transfection with oligos. Bar chart
shows the mean densitometry of p21 bands normalized to the data
in control oligo. Error bars are s.e.m. n¼ 3, **Po 0.01 versus control
oligo, *Po0.05 versus control oligo.
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This work has highlighted the very clear differences in
the functions of the Ras genes in HMC and MMC. There is
existing evidence for biochemical and cellular differences
in the functions of the indvidual Ras proteins Ha-, Ki-
and N-Ras.19,20 However, differences in Ras function when
comparing mice and humans have not been reported before.
In the context of renal therapies, the present results suggest
that the study of mouse models of in vivo Ras antagonism
may not provide a clear pathway to the development of
therapies in humans. Moreover, the role of Ha-Ras as an
antiapoptotic survival signal may need to be re-evaluated in
human cells, as much of the present literature is based on
murine and rodent cell work.
MATERIALS AND METHODS
Mesangial cell culture
HMC were obtained in primary culture from Clonetics Inc.
Wokingham, UK and were maintained in RPMI 1640 medium with
10% fetal calf serum. All HMC experiments were carried out
between passages 4 and 9. MMC were obtained in primary culture
using published techniques utilizing wild-type mice of strain C57B6
and mice that were null for p21(cip), p27(kip1) and double (p21,
p27 knockouts).10 Genotypes were confirmed by PCR, and the lack
of appropriate CDK-inhibitor expression in the knockout mesangial
cells was confirmed by RT-PCR and Western blotting for p21 and
p27. MMC were maintained in 20% fetal calf serum.
Oligonucleotide transfection
AS-oligos to individual human and mouse ras isoforms (Ki-ras,
Ha-ras and N-ras) were phosphorothioate forms with 2’-methoxy-
ethyl modifications supplied by Isis Pharmaceuticals (Carlsbad, CA).
These chemical forms of oligo have been shown to be of low cell
toxicity and to have half-lives in cell culture of over 72 h. A control
AS-oligo was used that targets the HIV promoter region and has
no sequence similarity to either mouse or human DNA; details of
this oligo have been reported previously.7 The specificity and activity
of the AS-oligos were demonstrated using RT-PCR for the three
ras mRNA transcripts as reported previously.7 The oligos were
transfected into the cells using LipofectinTM (Gibco BRL, Paisley,
UK) with 16–18 h of incubation at oligo concentrations of
200–400 nM. An initial mixture of lipofectin in 6–12 ml/ml OptiMEM
(Gibco) was vortexed, and incubated at room temperature for
45 min. AS-oligos were then added and the vortexed mixture was left
for a further 15 min before being added to the cells. The ratio of
lipofectin to oligo was 0.3 ml/10 pmol in each case.
Cell proliferation and apoptosis
To study the effects of ras oligos on proliferation, HMC were
rendered quiescent by serum starvation for 24 h, trypsinized and
seeded in triplicate into 96-well plates (5000 cells/well). MMC were
placed in 0.2% serum for 24 h. The rationale for this was that
preliminary studies showed that the absence of serum caused
significant cell loss particularly in the p21(,) mouse cells. Cells
were transfected with oligos targeting the individual ras genes and
with control oligos targeting part of the HIV-1 sequence as reported
previously.7 Viable cell numbers were determined by the MTS assay
(Cell titer 96, Promega, Southampton, UK), measuring absorbance
at 490 nm. The correlation between viable cell number and
absorbance at 490 nm is linear.
To test the hypothesis that specific Ras isoforms regulate
mesangial cell proliferation, DNA synthesis was assessed by BrdU
uptake. Cells were grown in 35 mm dishes, serum-stimulated and
transfected as described earlier. At 18 h after the addition of the
serum, used as a source of growth factors, BrdU (10 mM) (Sigma,
Gillingham, UK) was added to each dish for 16 h. Dishes were then
washed with phosphate-buffered saline (PBS), and fixed for 45 min
(3 volume 50 mM glycine and 7 volume ethanol). Cells were then
incubated in 4 M hydrochloric acid for 10 min, washed three times in
PBS and blocked in 5% goat serum/0.05% Tween/PBS for 15 min
before being incubated overnight in anti-BrdU antibody (1:100
dilution) (Sigma) at 41C. Cells were washed with PBS and incubated
for 30 min with TRITC-labelled anti-mouse IgG antibody (Sigma).
Cell nuclei were then counterstained with Hoechst 33342 at a
concentration of 10 mg/ml for 15 min (Sigma). Cells were then
visualized with a fluorescent microscope. BrdUþ ve cells would
stain nuclei red whereas all cell nuclei would stain blue. A total of
150 cells were counted from at least five different fields by an
observer in a blinded fashion.
To study the role of Ras isoforms in mesangial cell apoptosis,
HMC and MMC were grown in 35 mm dishes and transfected with
oligos as described before for 18 h. Hoechst 33342 was added (10 mg/
ml), and cells were incubated at 371C for 15 min. Cell nuclei were
then visualized under fluorescent microscopy. Apoptotic nuclei were
then identified as showing characteristic signs of chromatin
condensation and fragmentation. A total of 150 cells were counted
from at least five different fields.
PCR and Western blotting
For the initial detection of Ras isoform mRNAs, 40 cycles of PCR
were used. For human ras, the primers pairs used were as follows:
Ha-Ras forward CAAGAGTGCGCTGACCATCC, reverse CCGGAT
CTCACGCACCAAC; Ki-Ras forward AGTGCCTTGACGATACAG,
reverse GCATCATCAACACCCTGTCTT; and N-Ras forward GAAA
AGCGCACTGACAATCC, reverse CACCACACATGGCAATCCC.
For mouse, the primers were as follows: Ha-ras forward CATCCAG
CTGATCCAGAACC, reverse CATCTGAATCTTTCACCCGC; Ki-ras
forward TACATGAGAACTGGGGAGGG, reverse CTGTCTTGTCTT
CGCTGAGG; and N-ras forward CCTGACGATCCAGCTAATCC,
reverse ACTTGTTGCCTACCAGCACC. The reverse transcription
and amplification reactions were carried out using Promega’s Access
RT-PCR kit following the manufacturer’s instructions using 0.5mg
of total RNA. The annealing temperature used was 591C. The linear
phase of the amplification reaction was identified for each primer
pair by varying the cycle number from 10 to 40. Ten percent of
the reaction mixture was visualized on an agarose gel stained with
ethidium bromide and analyzed with densitometry. For each pair,
a cycle number in the linear phase of amplification was used in
the experiments to determine the effects of the AS-oligos on mRNA
levels for that isoform. As an internal standard, 18S ribosomal RNA
primers were used. These were supplied in the Ambion Quantum
RNA 18S internal standards kit (Ambion, Whitney, Oxfordshire,
UK).
For Western blotting experiments, cells were grown to 50–80%
confluence in 35 or 100 mm plates in Dulbecco’s modified Eagle’s
medium/Hams F12 Nut-mix containing 10% fetal calf serum.The
cell lysis detergent medium (designated PBSTDS) had the following
composition: 1 PBS, 1% Triton-X 100, 0.5% deoxycholate, 0.1%
SDS, leupeptin 0.5mg/ml, pepstatin 1.0 mg/ml, ethylenediaminete-
traacetic acid 1.0 mM and phenylmethylsulfonyl fluoride 0.2 mM.
Cells were either lysed at this point or, for experiments involving the
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AS-oligos, they were transfected for 16 h with 200 nM oligo in
OptiMEM. Following transfection, the medium was removed and
replaced with Dulbecco’s modified Eagle’s medium/Hams F12 Nut-
mix containing 10–20% fetal calf serum. After 24 h, the cells were
washed in PBS and lysed. Nuclear debris was removed by
centrifugation at 2300 g for 15 min at 41C.
Cell lysates were assayed for protein content by the Pierce protein
assay, and equal amounts of protein were made up to a uniform
volume of Western sample buffer comprising the following:
(6 concentrate) 0.5 M Tris (pH 6.8), 0.35 M sodium dodecyl sulfate,
glycerol 30%, 0.6 M dithiothreitol and 0.175 M bromphenol blue. Five
percent 2-mercaptoethanol was added immediately before loading,
and samples were heated to 1001C for 3 min; then, 10 mg protein
was loaded onto a 4/15% discontinuous polyacrylamide gel.
After transfer, protein detection was performed using monoclonal
antiobodies as follows: p21 (1:200 dilution; PharMingen, San Diego,
CA), Akt-P-S (Ser473) (1:1000 dilution; Cell Signaling Technology,
Beverly, MA) and anti-p27Kip1 antibody (1:1000 dilution; Trans-
duction Laboratories, Lexington, MA). Details of these methods
have been reported previously.21,22
After incubation with an appropriate secondary antibody coup-
led to horseradish peroxidase, blots were washed again for 25 min
and the detection was carried out using the enhanced chemilumi-
nescence system (Amersham Pharmacia Biotech, Amersham, UK).
Statistics
Statistical analysis was performed using analysis of variance followed
by Dunnetts test of significance or an unpaired t-test using Prism
software (Graphpad, San Diego, CA).
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